MATTER currently hosts forums in two discussion areas. Leaders from health systems and life sciences organizations are encouraged to participate.
Discussion areas
FORUM: HEALTH SYSTEMS TRANSFORMATION
Hospitals and health systems face unprecedented pressure to deliver greater value from their acute and primary care offerings. At the same time, they are expected to be more accountable for the quality and cost of care for their patients — even outside of the hospital walls. This series will convene health system leaders to evaluate some of the common challenges that organizations face in today’s rapidly evolving world. Together, participants will uncover key technological, process and infrastructure innovations to help accelerate clinical and business model innovation.
FORUM: LIFE SCIENCES
The discovery, translation and commercialization of early stage life sciences technologies require R&D, clinical and commercial capabilities to work effectively in concert. This series seeks to help faculty, students and entrepreneurs better understand the clinical and commercial needs of industry partners and, at the same time, help industry partners identify and invest in new technology assets.
FORUM: DIGITAL HEALTH TRANSFORMATION
Digital technologies are playing an increasing role in moving traditional asset-focused life sciences companies into ones focused on enhancing the patient and provider engagement and experience. In response to a more patient- and value-driven model of care, these life science companies are seeking opportunities to incorporate digital health solutions in their downstream marketing and sales strategies, as well as in upstream applications of novel drug discovery, development and clinical trials. This series aims to convene pharmaceutical and medical device leaders to problem-solve around key business challenges, with an eye towards uncovering key technological, process, and infrastructure innovations that will accelerate clinical and business model transformation.